Executive Scientific Director, Douglas University Mental Health Institute
Director, Neuroscience Division, Douglas University Mental Health Institute
Full Professor, Department of Psychiatry, McGill University
Dr. Alain Gratton is the Executive Scientific Director of the Douglas University Mental Health Institute and Director of the Neuroscience Division. He is also Professor of Psychiatry at McGill University, Faculty of Medicine.
Dr. Gratton holds a PhD in Psychobiology from Concordia University and a Post-doctoral degree in Neuropharmacology from the University of Colorado Medical School. Over the years, he has received several honours and awards from various institutions and has published numerous papers. He has also been invited to make scientific presentations at many renowned international conferences. He is an editorial Board member with a number of scientific journals and a Grant Review Committee Member with various granting councils and agencies. Over the years, Dr. Gratton has been the recipient of numerous research grants.
Elevated levels of stress are associated with an increased incidence of drug abuse in both laboratory animals and humans and the neurotransmitter, dopamine, has been implicated in this. Dr. Gratton investigates the role of dopamine in drug abuse, as well as exposure to stress. To conduct their investigations, Dr. Gratton and his team implement in vivo voltammetry –a state-of-the-art research technique – and other complimentary techniques to characterize the role of dopamine in mediating responses to acute and chronic stress, as well as to the administration of drugs of abuse and the development of drug dependence.